Horizon Pharma goes public at $9

Horizon Pharma ($HZNP) went public this morning, pricing 5.5 million shares at $9 a share. That's a little below the $10 to $12 range that it had hoped for, but not too bad considering some of the biotech IPOs that have floated at far bigger discounts so far this year. Horizon has also granted the underwriters a 30-day option to purchase up to an additional 825,000 shares at the initial public offering price to cover overallotments. Release

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.